The Lancet Commission on prostate cancer: planning for the surge in cases.

James ND, Tannock I, N'Dow J, Feng F, Gillessen S, Ali SA, Trujillo B, Al-Lazikani B, Attard G, Bray F, Compérat E, Eeles R, Fatiregun O, Grist E, Halabi S, Haran Á, Herchenhorn D, Hofman MS, Jalloh M, Loeb S, MacNair A, Mahal B, Mendes L, Moghul M, Moore C, Morgans A, Morris M, Murphy D, Murthy V, Nguyen PL, Padhani A, Parker C, Rush H, Sculpher M, Soule H, Sydes MR, Tilki D, Tunariu N, Villanti P, Xie LP

Open source

DOI
10.1016/s0140-6736(24)00651-2
Published
2024 Apr 27
Container
Lancet (London, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-24-00651-2,
  title = {The Lancet Commission on prostate cancer: planning for the surge in cases.},
  author = {James ND and Tannock I and N'Dow J and Feng F and Gillessen S and Ali SA and Trujillo B and Al-Lazikani B and Attard G and Bray F and Compérat E and Eeles R and Fatiregun O and Grist E and Halabi S and Haran Á and Herchenhorn D and Hofman MS and Jalloh M and Loeb S and MacNair A and Mahal B and Mendes L and Moghul M and Moore C and Morgans A and Morris M and Murphy D and Murthy V and Nguyen PL and Padhani A and Parker C and Rush H and Sculpher M and Soule H and Sydes MR and Tilki D and Tunariu N and Villanti P and Xie LP},
  year = {2024},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(24)00651-2},
  url = {https://doi.org/10.1016/s0140-6736(24)00651-2}
}

RIS

TY  - JOUR
TI  - The Lancet Commission on prostate cancer: planning for the surge in cases.
AU  - James ND
AU  - Tannock I
AU  - N'Dow J
AU  - Feng F
AU  - Gillessen S
AU  - Ali SA
AU  - Trujillo B
AU  - Al-Lazikani B
AU  - Attard G
AU  - Bray F
AU  - Compérat E
AU  - Eeles R
AU  - Fatiregun O
AU  - Grist E
AU  - Halabi S
AU  - Haran Á
AU  - Herchenhorn D
AU  - Hofman MS
AU  - Jalloh M
AU  - Loeb S
AU  - MacNair A
AU  - Mahal B
AU  - Mendes L
AU  - Moghul M
AU  - Moore C
AU  - Morgans A
AU  - Morris M
AU  - Murphy D
AU  - Murthy V
AU  - Nguyen PL
AU  - Padhani A
AU  - Parker C
AU  - Rush H
AU  - Sculpher M
AU  - Soule H
AU  - Sydes MR
AU  - Tilki D
AU  - Tunariu N
AU  - Villanti P
AU  - Xie LP
PY  - 2024
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(24)00651-2
UR  - https://doi.org/10.1016/s0140-6736(24)00651-2
ER  - 

APA

ND, J., I, T., J, N., F, F., S, G., SA, A., B, T., B, A., G, A., F, B., E, C., R, E., O, F., E, G., S, H., Á, H., D, H., MS, H., M, J., S, L., A, M., B, M., L, M., M, M., C, M., A, M., M, M., D, M., V, M., PL, N., A, P., C, P., H, R., M, S., H, S., MR, S., D, T., N, T., P, V., & LP, X. (2024). The Lancet Commission on prostate cancer: planning for the surge in cases.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(24)00651-2

Source records